AU2003230191A1 - Orally administrable pharmaceutical formulation comprising ephedrine hydrochloride and process for preparing the same - Google Patents

Orally administrable pharmaceutical formulation comprising ephedrine hydrochloride and process for preparing the same

Info

Publication number
AU2003230191A1
AU2003230191A1 AU2003230191A AU2003230191A AU2003230191A1 AU 2003230191 A1 AU2003230191 A1 AU 2003230191A1 AU 2003230191 A AU2003230191 A AU 2003230191A AU 2003230191 A AU2003230191 A AU 2003230191A AU 2003230191 A1 AU2003230191 A1 AU 2003230191A1
Authority
AU
Australia
Prior art keywords
preparing
same
pharmaceutical formulation
orally administrable
ephedrine hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003230191A
Other versions
AU2003230191A8 (en
Inventor
Nehru Babu Gaddipati
Ramachandran Radhakrishnan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Strides Pharma Science Ltd
Original Assignee
Strides Arcolab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/096,708 external-priority patent/US20030158264A1/en
Application filed by Strides Arcolab Ltd filed Critical Strides Arcolab Ltd
Publication of AU2003230191A8 publication Critical patent/AU2003230191A8/en
Publication of AU2003230191A1 publication Critical patent/AU2003230191A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AU2003230191A 2002-02-20 2003-02-20 Orally administrable pharmaceutical formulation comprising ephedrine hydrochloride and process for preparing the same Abandoned AU2003230191A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN128/DEL/2002 2002-02-20
IN128DE2002 2002-02-20
US10/096,708 2002-03-13
US10/096,708 US20030158264A1 (en) 2002-02-20 2002-03-13 Orally administrable pharmaceutical formulation comprising ephedrine hydrochloride and process for preparing the same
PCT/IN2003/000032 WO2003070156A2 (en) 2002-02-20 2003-02-20 Orally administrable pharmaceutical formulation comprising ephedrine hydrochloride and process for preparing the same

Publications (2)

Publication Number Publication Date
AU2003230191A8 AU2003230191A8 (en) 2003-09-09
AU2003230191A1 true AU2003230191A1 (en) 2003-09-09

Family

ID=27758878

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003230191A Abandoned AU2003230191A1 (en) 2002-02-20 2003-02-20 Orally administrable pharmaceutical formulation comprising ephedrine hydrochloride and process for preparing the same

Country Status (2)

Country Link
AU (1) AU2003230191A1 (en)
WO (1) WO2003070156A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1809349T3 (en) 2004-07-05 2009-12-07 Ziscoat N V Biocompatible coating for medical devices comprising molecular sieves
EP3053598A1 (en) 2015-02-06 2016-08-10 Faes Farma, S.A. Calcifediol soft capsules

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935242A (en) * 1984-10-05 1990-06-19 Warner-Lambert Company Novel drug delivery system for expectorants

Also Published As

Publication number Publication date
WO2003070156A2 (en) 2003-08-28
AU2003230191A8 (en) 2003-09-09
WO2003070156A3 (en) 2005-01-13

Similar Documents

Publication Publication Date Title
AU2002365516A1 (en) Benzamide derivatives, processes for their preparation, and their pharmaceutical use
AU2003244632A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
IL165977A (en) Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same
HUP0401647A3 (en) Novel betha-phenyl-alpha-oxy propionic acid derivatives, processes for their preparation and their use in the preparation of pharmaceutically important compounds
AU2003244649A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
HK1067558A1 (en) Pharmaceutical formulation having a masked taste and method for the production thereof
AU2002257582A1 (en) Pharmaceutical formulation
IL159217A0 (en) An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine
AU2002358676A1 (en) Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
AU2002364468A1 (en) Solid orally-dispersible pharmaceutical formulation
AU2003251290A1 (en) Process for preparation of polymorphic form ii of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof
AU2002329311A1 (en) Pharmaceutical formulation having a masked taste and method for the production thereof
AU2003216620A1 (en) Method of stabilizing bupropion hydrochloride tablets
HUP0401369A3 (en) Pharmaceutical formulation comprising (r)-bicalutamide, process for its preparation and use thereof
AU2003297367A1 (en) Process for preparing pharmaceutical formulations using supercritical fluids
GB2398005B (en) Orally administrable pharmaceutical formulation
AU2003230191A1 (en) Orally administrable pharmaceutical formulation comprising ephedrine hydrochloride and process for preparing the same
AU2003280387A1 (en) Pharmaceutical formulation comprising azithrocycin monohydrate
AU2002325614A1 (en) Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances
AU2003281698A1 (en) 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof
AU2003230190A1 (en) Orally administrable pharmaceutical formulation comprising pseudoephedrine hydrochloride and process for preparing the same
AU2003280065A1 (en) Bupropion hydrochloride solid dosage forms
AU2002337634A1 (en) Process for the preparation of bupropion hydrochloride
HUP0401371A3 (en) Pharmaceutical formulation containing an ltb4 antagonist and process for its preparation
IL175293A0 (en) Pharmaceutical formulation containing an ltb4 antagonist, method for the production thereof, and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase